{"created":"2021-03-01T06:28:45.442872+00:00","id":23495,"links":{},"metadata":{"_buckets":{"deposit":"81532670-c47d-4234-839d-5c07e7c27fc3"},"_deposit":{"id":"23495","owners":[],"pid":{"revision_id":0,"type":"depid","value":"23495"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00023495","sets":["453:456","471:537:538:1222"]},"item_7_alternative_title_1":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"Famotidine in the Treatment of Peptic Ulcer(Current Medical Therapy for Upper Gastrointestinal Ulcer Disease)"}]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1988-05","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"5","bibliographicPageEnd":"264","bibliographicPageStart":"261","bibliographicVolumeNumber":"102","bibliographic_titles":[{"bibliographic_title":"新潟医学会雑誌"},{"bibliographic_title":"新潟医学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The effect of famotidine on peptic ulcer disease was assessed in clinical trial in both inpatients and outpatients. Endoscopic evidence of ulcer healing and symptom evaluation were monitored in 59 cases (37 cases of gastric ulcer, 20 cases of duodenal ulcer, and 2 cases of gastro-duodenal ulcer) during and after treatment with famotidine at the dose of 40 mg per day for 8 weeks. The results were as follows: 1) Eighty-nine per cent of patients with gastric ulcer and 80% of those with duodenal ulcer showed evidence of ulcer healing, and their symptom almost improved in early phase. 2) There was no difference in healing rate between inpatients and outpatients. 3) Famotidine was useful not only for duodenal ulcers and gastric ulcers on the antrum to middle body but also for gastric ulcers on the upper bod regarded as a state of lower acid output. 4) Administration of famotidine did not have influence on the level of serum gastrin and prolactin. The results of this study demonstrate the usefulness of famotidine therapy in peptic ulcer disease.","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"141411","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Narisawa, Rintaro"}]},{"nameIdentifiers":[{"nameIdentifier":"141412","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Tomizawa, Mineo"}]}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟医学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"成澤, 林太郎"}],"nameIdentifiers":[{"nameIdentifier":"141409","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"富澤, 峰雄"}],"nameIdentifiers":[{"nameIdentifier":"141410","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-19"}],"displaytype":"detail","filename":"102(5)_261-264.pdf","filesize":[{"value":"820.4 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"102(5)_261-264.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/23495/files/102(5)_261-264.pdf"},"version_id":"2099a8c3-dacc-47bb-978c-a4ba9ce463b2"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"peptic ulcer","subitem_subject_scheme":"Other"},{"subitem_subject":"famotidine","subitem_subject_scheme":"Other"},{"subitem_subject":"消化性腫瘍","subitem_subject_scheme":"Other"},{"subitem_subject":"ファモチジン","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"4) H_2受容体拮抗薬による治療 : ファモチジンを中心に(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"4) H_2受容体拮抗薬による治療 : ファモチジンを中心に(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)"},{"subitem_title":"4) H_2受容体拮抗薬による治療 : ファモチジンを中心に(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","1222"],"pubdate":{"attribute_name":"公開日","attribute_value":"2016-04-05"},"publish_date":"2016-04-05","publish_status":"0","recid":"23495","relation_version_is_last":true,"title":["4) H_2受容体拮抗薬による治療 : ファモチジンを中心に(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:53:42.787140+00:00"}